Research Article

PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma

Figure 1

PLEKHA4 is overexpressed in several cancers including glioma. (a) Summary of PLEKHA4 expression analyses in multiple cancer types and their corresponding normal tissues. Red color indicates high PLEKHA4 expression in the corresponding cancer and blue color indicates low PLEKHA4 expression in the corresponding cancer. (b) PLEKHA4 expression in Sun brain (normal brain vs. glioblastoma) dataset was shown. (c) PLEKHA4 expression in Lee brain (neural stem cell vs. glioblastoma) dataset was shown. Note: indicates statistical significance; PLEKHA4 was among the top 1% overexpressed genes in glioma. (d, e) PLEKHA4 transcript expression levels in low-grade glioma (LGG; red; ), glioblastoma multiforme (GBM; red; ), and corresponding normal brain tissues (black; ) from the GEPIA datasets.
(a)
(b)
(c)
(d)
(e)